Clinical and Pathological Response to Primary Chemotherapy in Operable Breast Cancer

By Chollet P.   Charrier S.   Brain E.   Cure H.   van Praagh I.   Feillel V.   de Latour M.   Dauplat J.   Misset J.-L.   Ferriere J.-P.  

European Journal of Cancer, Vol. 33, Iss. 6, 1997-05 ,pp. : 862-866

Elsevier

Access to resources Recommend Favorite

Accuracy of mammography and echography versus clinical palpation in the assessment of response to primary chemotherapy in breast cancer patients with operable disease

By Fiorentino C.  

Breast Cancer Research and Treatment, Vol. 69, Iss. 2, 2001-09 ,pp. : 143-151

Springer Publishing Company

Access to resources Recommend Favorite

HER-2/neu status and response to CMF: retrospective study in a series of operable breast cancer treated with primary CMF chemotherapy

By Falo Catalina   Moreno Abelardo   Varela Mar   Lloveras Belen   Figueras Agnès   Escobedo Agustín  

Journal of Cancer Research and Clinical Oncology, Vol. 133, Iss. 7, 2007-07 ,pp. : 423-429

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic factors for survival after neoadjuvant chemotherapy in operable breast cancer - the role of clinical response

By Pierga J.-Y.   Mouret E.   Laurence V.   Dieras V.   Savigioni A.   Beuzeboc P.   Dorval T.   Palangie T.   Jouve M.   Pouillart P.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1089-1096

Elsevier

Access to resources Recommend Favorite

Prognostic significance of pathological complete response following neoadjuvant chemotherapy for operable breast cancer

By                

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 663-668

Spandidos Publications

Access to resources Recommend Favorite